Target intelligence / Profile preview

Cytochrome bo3 and Cytochrome bd terminal oxidases (Cyo/Cyd)

Target
Cyo/Cyd
Molecular classification
Enzyme, Oxidoreductase, Terminal oxidase, Quinol oxidase, Heme-copper oxidase (Cyo), Copper-free oxidase (Cyd)
01

Overview

Terminal oxidases CyoC and CydA are essential components of the bacterial respiratory chain, serving as the final enzymes that reduce molecular oxygen to water. Cytochrome bo3 (containing the CyoC subunit) is a heme-copper oxidase that typically functions under high-oxygen conditions and acts as a primary proton pump to generate a transmembrane electrochemical gradient. In contrast, Cytochrome bd (containing the CydA subunit) is a copper-free quinol oxidase with an exceptionally high affinity for oxygen, enabling bacterial survival and pathogenesis under microaerobic, hypoxic, or chemically stressful conditions, such as in the presence of nitric oxide or hydrogen sulfide. These oxidases are critical for the production of ATP via the proton motive force and are found exclusively in prokaryotes, making them highly attractive targets for the development of narrow-spectrum antibiotics. Inhibition of these enzymes, particularly in pathogens like Mycobacterium tuberculosis and Staphylococcus aureus, leads to energy depletion and bacterial death, especially when used in combination with inhibitors of the alternative bc1-aa3 respiratory pathway.

Other names
Cytochrome bo3 ubiquinol oxidaseCytochrome bd ubiquinol oxidaseCytochrome d terminal oxidaseCytochrome o ubiquinol oxidaseCyoABCDE complexCydAB complexQuinol:oxygen oxidoreductase
02

Mechanism of action

Inhibition of the quinol-binding site (Q-loop) or disruption of internal electron transfer between heme groups, preventing the reduction of oxygen and the generation of a proton motive force.

03

Biological functions

Aerobic respirationElectron transport chainOxygen reductionProton motive force generationStress responseBioenergetics
04

Disease associations

InfectionTuberculosisDrug-resistant bacterial infection
05

Safety considerations

Potential for off-target effects on human mitochondrial cytochrome c oxidase (though bacterial oxidases are structurally distinct)Development of antibiotic resistance through upregulation of alternative respiratory pathwaysBacteriostatic rather than bactericidal effect when only one of multiple redundant oxidases is inhibited
06

Interacting drugs

Aurachin C

6 more in the full profile.

07

Biomarkers

Bacterial oxygen consumption rateIntracellular ATP concentrationBacterial growth inhibition (MIC)Proton motive force (PMF) dissipationReactive oxygen species (ROS) production

Beyond the preview

Go deeper on Cytochrome bo3 and Cytochrome bd terminal oxidases (Cyo/Cyd).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome bo3 and Cytochrome bd terminal oxidases (Cyo/Cyd).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call